$0.27
▼ -2.0% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
Overview
52-week range
$0.16
$1.32
9% of range
Avg surprise (last 1)
-100.0%
Avg reaction (last 2)
-5.2%
0% positive
Latest IV / EM
6238%
EM ±368.4% · $1 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.10 | — | — | — | — | financials |
| Thu May 21, 2026 | Mar/2026 | $-0.02 | $-0.01 | -100.0% | -300.0% | -10.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.17 | — | — | — | — | financials |
| Mon Aug 18, 2025 | Jun/2025 | $-0.06 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $0.01 | — | — | — | -0.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.45 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.15 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.11 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.27 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.09 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.04 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $18M | — | $17M | $15M | $14M | — | $12M |
| Cost of revenue | $17M | $17M | — | $15M | $14M | $12M | — | $11M |
| Gross profit | $2M | $1M | — | $3M | $1M | $2M | — | $1M |
| Operating income | $-3M | $-2M | — | $-2M | $-3M | $-833,145 | — | $-2M |
| Net income | $-6M | $-3M | — | $-5M | $-3M | $-818,097 | — | $-8M |
| EPS (diluted) | $-0.10 | $-0.06 | — | $-0.17 | $-0.10 | $-0.03 | — | $-0.45 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2M | $514,702 | $715,674 | $889,441 | $655,503 | — | $315,105 | — |
| Inventory | $5M | $6M | $6M | $6M | $5M | $5M | $4M | $5M |
| Total current assets | $37M | $37M | $38M | $38M | $31M | $28M | $25M | $36M |
| Total assets | $61M | $62M | $65M | $69M | $62M | $57M | $54M | $65M |
| Long-term debt | $3M | $3M | — | $5M | $5M | $5M | — | $4M |
| Total liabilities | $41M | $43M | $47M | $46M | $36M | $31M | $30M | $30M |
| Total equity | $21M | $20M | $18M | $23M | $26M | $26M | $25M | $35M |